No Data
No Data
*ST Changyao: Report for the first quarter of 2025
Changyao Holdings: 2024 Annual Report
Changyao Holdings: 2024 Annual Report Summary
Changjiang Pharmaceutical Group (300391.SZ) will be subject to a delisting risk warning and will be suspended for one day on April 21.
Changjiang Pharmaceutical Group (300391.SZ) announced that the company's stocks will be suspended on April 21, 2025 (Monday) for...
Changjiang Pharmaceutical Group (300391.SZ) released its 2024 annual performance, reporting a net loss attributable to the parent company of 0.628 billion yuan.
Changjiang Pharmaceutical Group (300391.SZ) released its annual report for 2024, during the reporting period, the company achieved revenue of 1...
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected